| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Editorial Board
|
|
|
|
87 |
C |
p.
|
artikel
|
| 2 |
How did lomustine become standard of care in recurrent glioblastoma?
|
Weller, Michael
|
|
|
87 |
C |
p.
|
artikel
|
| 3 |
Incorporating Parp-inhibitors in Primary and Recurrent Ovarian Cancer: A Meta-analysis of 12 phase II/III randomized controlled trials
|
Ruscito, Ilary
|
|
|
87 |
C |
p.
|
artikel
|
| 4 |
Plasma circulating tumor DNA in pancreatic adenocarcinoma for screening, diagnosis, prognosis, treatment and follow-up: A systematic review
|
Abdallah, Raëf
|
|
|
87 |
C |
p.
|
artikel
|
| 5 |
Real world data in the era of Immune Checkpoint Inhibitors (ICIs): Increasing evidence and future applications in lung cancer
|
Pasello, Giulia
|
|
|
87 |
C |
p.
|
artikel
|
| 6 |
Reconsider radiation exposure from imaging during immune checkpoint inhibitor trials to reduce risk of secondary cancers in long-term survivors?
|
Knapen, Daan G.
|
|
|
87 |
C |
p.
|
artikel
|
| 7 |
Systemic adjuvant therapy for adult patients at high risk for recurrent melanoma: A systematic review
|
Baetz, Tara D.
|
|
|
87 |
C |
p.
|
artikel
|
| 8 |
The promise of selective MET inhibitors in non-small cell lung cancer with MET exon 14 skipping
|
Salgia, Ravi
|
|
|
87 |
C |
p.
|
artikel
|
Tijdschrift beschrijving